文献速递神经肌肉病

血清视黄醇结合蛋白4浓度与肌萎缩侧索硬化风险及预后的关联

Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis.
PubMed 文献 · JAMA Neurol · 2018-01-01

基于德国南部ALS登记处的病例对照研究(289例ALS患者与504名对照)及其中279例ALS患者的随访队列,发现血清RBP4浓度中位数在ALS患者中低于对照(54.0 vs 59.5 mg/L),最高与最低四分位组比较的ALS风险比值比为0.36(95%CI 0.22-0.59),且RBP4作为连续变量与ALS生存呈负相关。

要点

  • 血清RBP4浓度中位数ALS患者低于对照(54.0 vs 59.5 mg/L)。
  • RBP4最高与最低四分位组比较,ALS风险比值比为0.36(95%CI 0.22-0.59)。
  • 在279例ALS患者中,RBP4作为连续变量与生存呈负相关。

核心结论

  • RBP4与ALS风险及预后呈负相关,提示维生素A代谢或胰岛素信号受损可能参与其中。
  • 作者认为需要包括前瞻性设计和其他生物标志物在内的进一步研究来阐明胰岛素抵抗在ALS发病机制中的作用。

研究设计与样本

  • 病例对照设计用于评估ALS危险因素;队列设计用于评估ALS病例内的预后因素。
  • 病例应答率为64.8%,对照应答率为18.7%;分析日期为2016年4月至2017年5月。
  • 纳入289例ALS患者(平均[SD]年龄65.7[10.5]岁;172例[59.5%]男性)和504名对照(平均[SD]年龄66.3[9.8]岁;299名[59.3%]男性)。

主要发现

  • 与对照相比,ALS病例的特征为较低的体重指数、较低的教育程度、吸烟、较轻的职业工作强度和自报糖尿病。
  • 血清RBP4浓度中位数ALS病例低于对照(54.0 vs 59.5 mg/L)。
  • 在多变量模型中,RBP4浓度升高与ALS风险降低相关(最高与最低四分位组比值比0.36;95%CI 0.22-0.59;趋势P<.001),进一步调整肾功能、瘦素和脂联素后该关联持续存在。
  • 在279例ALS病例中,中位随访14.5个月期间104例死亡(平均[SD]年龄68.9[10.3]岁;56例[53.9%]男性)。
  • 在该ALS队列中,血清RBP4浓度作为连续变量与生存呈负相关。

关键数值与推荐

  • ALS风险的多变量比值比(最高与最低四分位组比较):0.36(95%CI 0.22-0.59;趋势P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需要包括前瞻性设计和其他生物标志物在内的进一步研究来阐明胰岛素抵抗在ALS发病机制中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Knowledge about the metabolic states of patients with amyotrophic lateral sclerosis (ALS) may provide a therapeutic approach. OBJECTIVE: To investigate the association between the onset and prognosis of ALS and serum retinol-binding protein 4 (RBP4) concentration as a biomarker for insulin resistance and vitamin A metabolism. DESIGN, SETTING, AND PARTICIPANTS: Case-control design for risk factors of ALS; cohort design for prognostic factors within ALS cases. Between October 1, 2010, and June 30, 2014, a population-based case-control study with randomly selected controls was established based on the ALS Registry Swabia in southern Germany, with a target population of 8.4 million inhabitants. Response rates were 64.8% among the cases and 18.7% among the controls. The dates of analysis were April 2016 to May 2017. MAIN OUTCOMES AND MEASURES: Serum samples were measured for RBP4. Information on covariates was assessed by an interview-based standardized questionnaire. Main outcomes and measures were adjusted odds ratios for risk of ALS associated with serum RBP4 concentration, as well as time to death associated with RBP4 concentration at baseline in ALS cases only. Conditional logistic regression was applied to calculate multivariable odds ratios for risk of ALS. Survival models were used in cases only to appraise their prognostic value. RESULTS: Data from 289 patients with ALS (mean [SD] age, 65.7 [10.5] years; 172 [59.5%] male) and 504 controls (mean [SD] age, 66.3 [9.8] years; 299 [59.3%] male) were included in the case-control study. Compared with controls, ALS cases were characterized by lower body mass index, less educational attainment, smoking, light occupational work intensity, and self-reported diabetes. The median serum RBP4 concentration was lower in ALS cases than in controls (54.0 vs 59.5 mg/L). In the multivariable model, increasing RBP4 concentration was associated with reduced odds for ALS (top vs bottom quartile odds ratio, 0.36; 95% CI, 0.22-0.59; P for trend <.001), which persisted after further adjustment for renal function and for leptin and adiponectin. Among 279 ALS cases during a median follow-up of 14.5 months, 104 died (mean [SD] age, 68.9 [10.3] years; 56 [53.9%] male). In this ALS cohort, an inverse association was found between serum RBP4 concentration as a continuous measure and survival. CONCLUSIONS AND RELEVANCE: RBP4 was inversely related to risk for and prognosis of ALS, suggesting that vitamin A metabolism or impaired insulin signaling could be involved. Further research, including a prospective design and other biological markers, is necessary to clarify the role of insulin resistance in the pathogenesis of ALS.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Rosenbohm A, Nagel G, Peter RS, et al. Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis. JAMA Neurol. 2018. PMID: 29482216. doi:10.1001/jamaneurol.2017.5129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。